21 results
8-K
EX-99.1
NUVL
Nuvalent Inc - Ordinary Shares
27 Feb 24
Nuvalent Highlights Pipeline Progress, Reiterates Key Anticipated Milestones and Reports Fourth Quarter and Full Year 2023 Financial Results
6:38am
Executive Officer at Nuvalent. “Backed by a dedicated and expert team, and a strong balance sheet, we are well positioned to continue delivering on our
8-K
EX-99.1
NUVL
Nuvalent Inc - Ordinary Shares
11 May 23
Nuvalent Announces Anticipated Timing of Preliminary Phase 1 Dose-Escalation Data for NVL-655 and Reports First Quarter 2023 Financial Results
6:39am
. With a solid cash position and an expert team, we are well-positioned to deliver on both our near- and long-term goals.”
First Quarter 2023 Financial
PRE 14A
NUVL
Nuvalent Inc - Ordinary Shares
13 Apr 23
Preliminary proxy
4:30pm
financial expert” as defined by applicable SEC rules and that each of the members of our audit committee possesses the financial sophistication required
DEF 14A
a0q71ye
29 Apr 22
Definitive proxy
4:07pm
8-K
EX-99.1
zxt9q aii48
10 Nov 21
Nuvalent Reports Pipeline Progress and Third Quarter 2021 Financial Results
6:44am
8-K
EX-3.2
qmh4me 3z1ozflfnyty
2 Aug 21
Amendments to Articles of Incorporation or Bylaws
4:06pm
424B4
cwqmzr3y
30 Jul 21
Prospectus supplement with pricing info
4:06pm
S-1/A
mmgiobrf8zua0 z0o
22 Jul 21
IPO registration (amended)
6:07am
CORRESP
sxrths8dp2
16 Jul 21
Correspondence with SEC
12:00am
S-1
EX-10.4
vg2 2td73gkra2x
7 Jul 21
IPO registration
12:00am
S-1
coaj0oe4c6c07dl
7 Jul 21
IPO registration
12:00am
S-1
EX-3.5
py4ddi6k ej18lwy
7 Jul 21
IPO registration
12:00am
S-1
EX-10.5
0dcd2i
7 Jul 21
IPO registration
12:00am
S-1
EX-10.1
0be006c 6l8i
7 Jul 21
IPO registration
12:00am
S-1
EX-3.4
t43dr99d4jpynwoyes30
7 Jul 21
IPO registration
12:00am
DRS
EX-10.1
cq1ohq 51o
28 May 21
Draft registration statement
12:00am
DRS
1rt g8k4fo
28 May 21
Draft registration statement
12:00am